Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Onchocerca volvulus | 0.0286 | 0.3292 | 1 | |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.024 | 0.2725 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0185 | 0.0646 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0228 | 0.0043 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.4787 | 0.4689 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.024 | 0.2725 | 0.9507 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.3292 | 1 |
Onchocerca volvulus | 0.006 | 0.0518 | 0.1071 | |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0185 | 0.0646 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.024 | 0.2725 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.024 | 0.2725 | 0.9507 |
Onchocerca volvulus | 0.0036 | 0.0228 | 0.0137 | |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.024 | 0.2725 | 0.2588 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.024 | 0.2725 | 0.2588 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0228 | 0.0043 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.4787 | 0.4689 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.024 | 0.2725 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0228 | 0.0795 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.1649 | 0.1492 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0228 | 0.0043 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0178 | 0.0621 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0228 | 0.0043 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.1799 | 0.1644 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2867 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0212 | 0.0027 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.1799 | 0.1644 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.024 | 0.2725 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0185 | 0.0646 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0185 | 0.0646 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.0518 | 0.0339 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.024 | 0.2725 | 0.2588 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.1799 | 0.1644 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.024 | 0.2725 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0518 | 0.1808 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0185 | 0.0646 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.024 | 0.2725 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.024 | 0.2725 | 0.9507 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.024 | 0.2725 | 0.9507 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.024 | 0.2725 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.024 | 0.2725 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0228 | 0.0043 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.1649 | 0.1492 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0228 | 0.0043 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.1649 | 0.1492 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2867 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0228 | 0.0795 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0228 | 0.0043 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.3162 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 23.9341 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.